William P Forbes
CIK 1314760 · EVP, Chief Development Officer · last filed 2026-06-08
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$94.2K
Companies
4
Total Filings
72
Lifetime Open-Market Net
-$16.39M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| HRTX | EVP, Chief Development Officer | 221,611 | $0.40 | $88.7K | $74.2K | 22 | 2026-06-08 |
| XAIR | Director | 14,855 | $0.37 | $5.5K | $90.7K | 10 | 2025-11-06 |
| TRVI | Chief Development Officer | — | $14.21 | — | $0 | 4 | 2022-07-01 |
| SALIX PHARMACEUTICALS LTD (SLXP) Delisted | President, Medical R&D and CDO | 51,714 | — | — | -$16.55M | 35 | 2015-03-11 |
Recent Filings · Page 5 of 8
72 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2014-11-14 | SALIX PHARMACEUTICALS LTD (SLXP) Delisted | Mixed | +6,371 | -$746.5K | EDGAR |
| 2014-08-26 | SALIX PHARMACEUTICALS LTD (SLXP) Delisted | Grant (A) | +19,809 | $3.14M | EDGAR |
| 2014-07-03 | SALIX PHARMACEUTICALS LTD (SLXP) Delisted | Tax (F) | −1,971 | -$243.1K | EDGAR |
| 2014-01-10 | SALIX PHARMACEUTICALS LTD (SLXP) Delisted | Mixed | — | -$580.2K | EDGAR |
| 2014-01-06 | SALIX PHARMACEUTICALS LTD (SLXP) Delisted | Tax (F) | −8,851 | -$796.1K | EDGAR |
| 2013-07-26 | SALIX PHARMACEUTICALS LTD (SLXP) Delisted | Mixed | — | -$640.8K | EDGAR |
| 2013-07-03 | SALIX PHARMACEUTICALS LTD (SLXP) Delisted | Tax (F) | −4,835 | -$319.8K | EDGAR |
| 2013-04-22 | SALIX PHARMACEUTICALS LTD (SLXP) Delisted | Grant (A) | +23,741 | $1.16M | EDGAR |
| 2013-04-12 | SALIX PHARMACEUTICALS LTD (SLXP) Delisted | Mixed | +4,327 | -$200.3K | EDGAR |
| 2013-01-04 | SALIX PHARMACEUTICALS LTD (SLXP) Delisted | Tax (F) | −5,052 | -$204.5K | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.